Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course

ICI-associated vasculitis are rare, heterogeneous, but can be severe requiring urgent multidisciplinary management with aggressive treatment.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2024-12-23
DOI
https://doi.org/10.1093/rheumatology/keae711
Citations
8
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
2.26

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course

R. Outh, Alejandra Flores-Chávez, Nihan Acar‐Denizli, F. Closs-Prophette et al.
8 citations
Lara D. Veeken
Peptidase Inhibition and Analysis
2.26
article

Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course

R. Outh, Alejandra Flores-Chávez, Nihan Acar‐Denizli, F. Closs-Prophette, Marie Kostine, Sabine Messayke, Ángel Robles‐Marhuenda, J.D. Karam, Munther A. Khamashta, Manuel Ramos‐Casals, Arianne Laparra, Timothy R. D. J. Radstake, Rakiba Belkhir, Clifton O Bingham, Chiara Baldini, Maria Eugenia Suarez-Almazor, Leonard Calabrese, Thierry Schaeverbeke, Pilar Brito‐Zerón, Hendrik Schulze‐Koops, Karolina Gente, Jean‐Marie Michot, Olivier Lambotte, Alexandre Galvagni, Karijn P.M. Suijkerbuijk, Caroline Robert, Juan Ignacio Ruiz, José Salvador García Morillo, Jacques‐Eric Gottenberg, Xavier Mariette, Philippe Kerschen, Anne Laure Voisin, N. Chanson, O. Lambotte
article en
8 citations

Abstract

ICI-associated vasculitis are rare, heterogeneous, but can be severe requiring urgent multidisciplinary management with aggressive treatment.

Lara D. VeekenVol. 64(6)
The University of Texas MD Anderson Cancer Center (US), Inserm (FR), Centre Hospitalier de Luxembourg (LU), Utrecht University (NL), Heidelberg University (DE), Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), Université Paris-Saclay (FR), Hospital Universitario La Paz (ES), Institut Gustave Roussy (FR), University Hospital Heidelberg (DE), University Medical Center Utrecht (NL), Centre Hospitalier de Perpignan (FR), Centre Hospitalier Universitaire Amiens-Picardie (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospital Clínic de Barcelona (ES), Centre Hospitalier du Mans (FR), Cancer Genomics Centre (NL), CEA Paris-Saclay (FR), Infectious Disease Models and Innovative Therapies (FR), Hospital Universitario Virgen del Rocío (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Bicêtre Hospital (FR), Universitat de Barcelona (ES)
Université Paris-Saclay, Assistance publique-Hôpitaux de Paris
Good health and well-being
Openalex Percentile: Top 9%
Peptidase Inhibition and Analysis
2.26
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.